ZDHHC17 and hepatocellular carcinoma: For example, a 2024 study in hepatocellular carcinoma showed that the palmitoyltransferases ZDHHC17 and ZDHHC24 can palmitoylate AKT, anchoring it to the plasma membrane and significantly increasing AKT kinase activity (37).